Home › Funds › CLIFFORD SWAN INVESTMENT COUNSEL LLC › EW

CLIFFORD SWAN INVESTMENT COUNSEL LLC position in EW

EDWARDS LIFESCIENCES CORP · Health Care

CLIFFORD SWAN INVESTMENT COUNSEL LLC reported holding 243,773 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$21.0M, representing 0.77% of its reported portfolio and ranking #40 among its reported holdings. CLIFFORD SWAN INVESTMENT COUNSEL LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)243.77K sh
Reported value held$21.04M
Portfolio Weight0.77%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CLIFFORD SWAN INVESTMENT COUNSEL LLC's EW position evolved

CLIFFORD SWAN INVESTMENT COUNSEL LLC first disclosed a stake in EW in Q3 2023 at 254,319 shares (US$17.6M). The position peaked in Q1 2024 at 240,002 shares, worth US$22.9M. Across 13 filings, CLIFFORD SWAN INVESTMENT COUNSEL LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 243,773 shares valued at US$21.0M — a reduction of -1,340 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 254.32K $17.62M New
Q4 2023 253.26K $19.31M Hold
Q1 2024 240.00K $22.93M Reduce
Q2 2024 239.39K $22.11M Hold
Q3 2024 254.43K $16.79M Add
Q4 2024 253.59K $18.77M Hold
Q1 2025 253.43K $18.37M Hold
Q2 2025 253.42K $19.82M Hold
Q3 2025 253.29K $19.70M Hold
Q4 2025 251.56K $21.45M Reduce
Q1 2026 250.45K $20.06M Hold
Q2 2026 245.11K $22.17M Reduce
Q3 2026 243.77K $21.04M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has CLIFFORD SWAN INVESTMENT COUNSEL LLC held EW?

CLIFFORD SWAN INVESTMENT COUNSEL LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CLIFFORD SWAN INVESTMENT COUNSEL LLC's current position in EW?

As of Q3 2026, CLIFFORD SWAN INVESTMENT COUNSEL LLC holds 243.77K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $21.04M, representing 0.77% of its reported portfolio and ranking #40.

Has CLIFFORD SWAN INVESTMENT COUNSEL LLC been buying or selling EW?

In the latest 13F filing (Q3 2026), CLIFFORD SWAN INVESTMENT COUNSEL LLC reduced its position in EW. The position peaked in Q1 2024 at 240.00K shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.